COENZYME Q10 - 30MG (UBIQUINONE) 30 MG — DIN 02237475
UBIDECARENONE : 30 MG · PHARMETICS (2011) INC · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is COENZYME Q10 - 30MG (UBIQUINONE)?
COENZYME Q10 - 30MG (UBIQUINONE) 30 MG contains UBIDECARENONE : 30 MG. It is listed in the Health Canada Drug Product Database under DIN 02237475, held by PHARMETICS (2011) INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Ubidecarenone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
50 holders have a Canadian DIN containing Ubidecarenone, across 77 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SISU INC. | 4 | 0 | BIOGARD UBIQUINONE CAP 30MG, BIOMED CO Q 10, CO-Q10 - CAP 60MG, CO-Q10 CAP 30MG | No marketed DIN |
| SWISS HERBAL REMEDIES LTD. | 4 | 0 | COENZYME CO Q10 CAP 10MG, COENZYME CO Q10 CAP 30MG, COENZYME Q10, COENZYME Q10 UBIQUINONE 60MG - CAP | No marketed DIN |
| HOLISTA HEALTH (CANADA) INC. | 3 | 0 | CO-ENZYME Q-10, COENZYME Q10 (60 MG), COENZYME Q10 30 MG | No marketed DIN |
| ORGANIKA HEALTH PRODUCTS INC. | 3 | 0 | COENZYME Q10 60MG CAP, COENZYME Q10 80MG, COENZYME Q10 CAP 15MG | No marketed DIN |
| PHARMETICS (2011) INC | 3 | 0 | COENZYME Q10 - 10MG (UBIQUINONE), COENZYME Q10 - 30MG (UBIQUINONE), COENZYME Q10 60MG CAPSULES | No marketed DIN |
| PRAIRIE NATURALS | 3 | 0 | COENZYME Q10, COENZYME Q10 100MG, COENZYME Q10 WITH HAWTHORN EXTRACT AND CITRUS BIOFLAVONOIDS | No marketed DIN |
| WN PHARMACEUTICALS LTD. | 3 | 0 | COENZYME Q10 100 MG, COENZYME Q10 30MG, COENZYME Q10 60MG | No marketed DIN |
| ALBI NATURALS | 2 | 0 | CO Q 10 - 50MG CAP, ROCKY MOUNTAIN CO Q 10 CAP 25MG | No marketed DIN |
| ALIVE VITAMINS | 2 | 0 | CO-ENZYME Q10 30MG CAPSULES, CO-ENZYME Q10 60MG CAPSULES | No marketed DIN |
| GAHLER ENTERPRISES LTD. | 2 | 0 | CO-ENZYME Q10 CAP 30MG, COENZYME Q10 60MG CAP | No marketed DIN |
| NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | 2 | 0 | CO-ENZYME Q10 100MG, COENZYME Q10 50 MG | No marketed DIN |
| PREFERRED NUTRITION INC. | 2 | 0 | COENZYME Q10 100MG, COENZYME Q10 30MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 30 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Ubidecarenone |
|---|---|
| ATC code | C01EB09 |
| AHFS class | 88:30.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02237475 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2237475 |
| Brand name | COENZYME Q10 - 30MG (UBIQUINONE) |
| Generic / active ingredient | UBIDECARENONE : 30 MG |
| Market authorization holder | PHARMETICS (2011) INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | C01EB09 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C01EB |
| Current status | CANCELLED POST MARKET |
| Status date | 30-Jul-2009 |
| Original market date | 1998-11-02 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 77 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTI-UBIQUINONE 50 CAP 50MG | 50 MG | CAPSULE | ACTI-FORM LTD. | CANCELLED POST MARKET | 01901257 |
| BIOGARD UBIQUINONE CAP 30MG | 30 MG | CAPSULE | SISU INC. | CANCELLED POST MARKET | 02065894 |
| BIOMED CO Q 10 | 100 MG | CAPSULE | SISU INC. | CANCELLED POST MARKET | 02231947 |
| CELL TECH COENZYME Q10 - CAP 30MG | 30 MG | CAPSULE | CELL TECH | CANCELLED POST MARKET | 02215411 |
| CELLSPARC 360 | 60 MG | CAPSULE | AIM INTERNATIONAL, INC. | CANCELLED POST MARKET | 02230519 |
| CO Q 10 - 50MG CAP | 50 MG | CAPSULE | ALBI NATURALS | CANCELLED POST MARKET | 02121735 |
| CO-ENZYME Q-10 | 30 MG | CAPSULE | HOLISTA HEALTH (CANADA) INC. | CANCELLED POST MARKET | 02147351 |
| CO-ENZYME Q-10 | 30 MG | CAPSULE | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | 02165147 |
| CO-ENZYME Q-10 CAPSULES | 30 MG | CAPSULE | ASHBURY RESEARCH CORPORATION | CANCELLED PRE MARKET | 02239440 |
| CO-ENZYME Q10 100MG | 100 MG | CAPSULE | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | CANCELLED POST MARKET | 02240171 |
2 · Same class — other molecules in ATC C01EB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Mavacamten | CAMZYOS | 4 | 4 | Yes |
| Adenosine | ADENOCARD - LIQ RAPID BOLUS IV 3MG/ML · ADENOCARD INJECTION -PRE-FILLED SYRINGE · ADENOCARD LIQ IV 3MG/ML · ADENOCARD LIQ IV 3MG/ML (PRE-FILLED SYRINGE) · +5 more | 13 | 3 | Yes |
| Ranolazine | CORZYNA | 4 | 2 | Yes |
| Ivabradine | LANCORA | 2 | 2 | Yes |
| Ubidecarenone | ACTI-UBIQUINONE 50 CAP 50MG · BIOGARD UBIQUINONE CAP 30MG · BIOMED CO Q 10 · CELL TECH COENZYME Q10 - CAP 30MG · +58 more | 77 | 0 | Not in Canada |
| Indometacin | INDOCID P.D.A. · RHODACINE - SUP 100MG | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C01E
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C01EA | Alprostadil | 3 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.